These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2405089)

  • 1. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
    Fagerberg B; Berglund A; Holme E; Wilhelmsen L; Elmfeldt D
    J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T; Lithell H; Selinus I; Berne C
    BMJ; 1989 Apr; 298(6681):1152-7. PubMed ID: 2500169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.
    Pesant Y; Marc-Aurèle J; Bielmann P; Alaupovic P; Cartier P; Bichet D; Thibault G; Lupien PJ
    Am J Ther; 1999 May; 6(3):137-47. PubMed ID: 10423656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
    Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
    Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
    J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
    Darmansjah I; Wong E; Setiawati A; Moeloek D; Irawati D; Siagian M; Muchtar A
    J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S; Kendall M
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being.
    Walle PO; Westergren G; Dimenäs E; Olofsson B; Albrektsen T
    J Clin Pharmacol; 1994 Jul; 34(7):742-7. PubMed ID: 7929868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.
    Morley CA; Cavalcanti C; Perrins EJ; Sutton R
    Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the metabolic effects of captopril and atenolol on glucose, insulin and lipoproteins in patients with mild-to-moderate essential hypertension.
    Maritz FJ; Weich HF; Schoeman HS
    S Afr Med J; 1995 Dec; 85(12 Pt 2):1342-5. PubMed ID: 8600607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects--a comparison with atenolol.
    Dimenäs ES; Dahlöf CG; Heibel B; Moore RG; Olofsson BK; Westergren GE; Lücker PW
    Eur J Clin Pharmacol; 1990; 38(6):571-8. PubMed ID: 2373131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
    Head A; Maxwell S; Kendall MJ; Eagles C
    Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
    Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
    Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
    Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.